Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs

Abstract

BackgroundInfluenza virus spreads infection by two main surface glycoproteins, namely hemagglutinin (HA) and neuraminidase (NA). NA cleaves the sialic acid receptors eventually releasing newly formed virus particles which then invade new cells. Inhibition of NA could limit the replication of virus to one round which is insufficient to cause the disease.ResultsAn experimentally reported series of acylguanidine zanamivir derivatives was used to develop GQSAR model targeting NA in different strains of influenza virus, H1N1 and H3N2. A combinatorial library was developed and their inhibitory activities were predicted using the GQSAR model.ConclusionThe top leads were analyzed by docking which revealed the binding modes of these inhibitors in the active site of NA (150-loop). The top compound (AMA) was selected for carrying out molecular dynamics simulations for 15 ns which provided insights into the time dependent dynamics of the designed leads. AMA possessed a docking score of −8.26 Kcal/mol with H1N1 strain and −7.00 Kcal/mol with H3N2 strain. Ligand-bound complexes of both H1N1 and H3N2 were observed to be stable for 11 ns and 7 ns respectively. ADME descriptors were also calculated to study the pharmacokinetic properties of AMA which revealed its drug-like properties.Electronic supplementary materialThe online version of this article (doi:10.1186/s12859-016-1374-1) contains supplementary material, which is available to authorized users.

Inhibition of H1N1 influenza virus by selenium nanoparticles loaded with zanamivir through p38 and JNK signaling pathways

“…5,6 Nevertheless, it has a strong molecular polarity, which leads to low absorbability by oral administration, making its administering inconvenient for children. 7 Selenium (Se) is an essential trace element in human body. Adequate Se helps to maintain activity of NK cells and promote proliferation of T cells, which are signicant for antiviral immunity.…”

Updates on Drug Designing Approach Through Computational Strategies: a Review

“…HIA is another essential factor of significant consideration during the drug design, optimization, and selection of orally active drug molecules. The intestine is the most important site of absorption for an orally consumable drug and an important parameter in the search for potential drug-likeness of a lead molecule [ 206 , 207 ].…”

Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies

“…In all, 11 residues from all drugs have been identified that participate in hydrogen bond formation. These are: ARG118, GLU119, ASP151, ARG152, SER153, ARG156, TRP178, GLU227, GLU277, ARG371, GLU425 [10,42] and are shown in (Table 2 in Supplementary material). Out of these 11, those 6 common residues (GLU119, ARG152, GLU227, ARG371, ARG156, GLU277) have been selected that are present for the maximum time duration at different time intervals.…”